209 related articles for article (PubMed ID: 34801560)
1. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
Wang F; Xu C; Li G; Lv P; Gu J
Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
[TBL] [Abstract][Full Text] [Related]
2. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy.
Zhao Z; Wu J; Liu X; Liang M; Zhou X; Ouyang S; Yao J; Wang J; Luo B
Cancer Lett; 2018 May; 421():73-81. PubMed ID: 29458142
[TBL] [Abstract][Full Text] [Related]
3. The HSP90 inhibitor, XL888, enhanced cell apoptosis via downregulating STAT3 after insufficient radiofrequency ablation in hepatocellular carcinoma.
Sun C; Bai M; Ke W; Wang X; Zhao X; Lu Z
Life Sci; 2021 Oct; 282():119762. PubMed ID: 34186047
[TBL] [Abstract][Full Text] [Related]
4. Targeting autophagy enhances heat stress-induced apoptosis via the ATP-AMPK-mTOR axis for hepatocellular carcinoma.
Jiang J; Chen S; Li K; Zhang C; Tan Y; Deng Q; Chai Y; Wang X; Chen G; Feng K; Zhang L; Xie CM; Ma K
Int J Hyperthermia; 2019; 36(1):499-510. PubMed ID: 31007109
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
[TBL] [Abstract][Full Text] [Related]
6. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop.
Wang X; Deng Q; Feng K; Chen S; Jiang J; Xia F; Ma K; Bie P
Oncol Rep; 2018 Jul; 40(1):241-251. PubMed ID: 29749472
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
8. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
Su T; Huang M; Liao J; Lin S; Yu P; Yang J; Cai Y; Zhu S; Xu L; Peng Z; Peng S; Chen S; Kuang M
Hepatology; 2021 Sep; 74(3):1339-1356. PubMed ID: 33638162
[TBL] [Abstract][Full Text] [Related]
9. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis.
Zhang Y; Yang H; Sun M; He T; Liu Y; Yang X; Shi X; Liu X
Pharmacol Rep; 2020 Oct; 72(5):1370-1382. PubMed ID: 32301055
[TBL] [Abstract][Full Text] [Related]
10. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation triggers the migration of hepatocellular carcinoma cells by suppressing miR-148a-5p.
Wang H; Cao Y; Hu K; Li Q; Yang Y; Wang L; Qin X; Qiao B; Cheng L; Li P; Dui W
Biol Chem; 2020 Jul; 401(8):985-994. PubMed ID: 32142478
[TBL] [Abstract][Full Text] [Related]
14. GSDME has prognostic and immunotherapeutic significance in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Liang X; Liu Q; Zhu S; Li Z; Chen H; Su Z
Transl Oncol; 2024 Jan; 39():101796. PubMed ID: 37862939
[TBL] [Abstract][Full Text] [Related]
15. Targeting N
Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
[TBL] [Abstract][Full Text] [Related]
16. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial ROS driven by NOX4 upregulation promotes hepatocellular carcinoma cell survival after incomplete radiofrequency ablation by inducing of mitophagy via Nrf2/PINK1.
Peng C; Li X; Ao F; Li T; Guo J; Liu J; Zhang X; Gu J; Mao J; Zhou B
J Transl Med; 2023 Mar; 21(1):218. PubMed ID: 36964576
[TBL] [Abstract][Full Text] [Related]
18. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
[TBL] [Abstract][Full Text] [Related]
19. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
[TBL] [Abstract][Full Text] [Related]
20. Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
Su T; Liao J; Dai Z; Xu L; Chen S; Wang Y; Peng Z; Zhang Q; Peng S; Kuang M
Oncogene; 2018 Jun; 37(26):3514-3527. PubMed ID: 29559743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
